ETHIONAMIDE, 125mg, disp. tab., blister
Valid Article
ETHIONAMIDE
Therapeutic Action
Thionamide, bacteriostatic
Ethionamide and prothionamide belong to the same therapeutic group.
Indications
Drug-Resistant tuberculosis (DR-TB), in combination with other TB medicines
Instructions for use
The 125 mg dispersible tablet is intended for paediatric use. To be dispersed in 10 ml water.
Must be taken with food and/or at bedtime to limit gastrointestinal disturbances.
Blister packaging is the packaging of choice for antituberculosis medicines due to the unstable nature of some of them when exposed to higher temperatures and humidity.
Bulk packaging (hospital packs) should only be used in special circumstances or in case of unexpected problems in availability of the blister presentation.
The quantity to be ordered is calculated per tablet, not per blister.
Precautions for Use
Do not administer to patients with severe hepatic impairment..
May cause gastrointestinal disturbances.
Contraindicated during pregnancy.
Storage
Below 25°C - Protect from sunlight